.png)
We are a movement, not just a start-up, founded with 41 pathologists who know what’s at stake behind every slide: a patient, a family, a future.
Built with expert pathologists & oncologists
Our models are trained on expert annotations contributed by practicing pathologists not crowd-sourced, not synthetic. We co-develop with the very people who use the tools.
Clinically relevant, not just technically impressive
We don’t just optimize performance, we optimize for decisions. Our models answer questions clinicians actually face, like prognosis, response prediction, and biomarker scoring.
Validated on real-world, multi-center cohorts
Our algorithms are validated on large, multi-institutional cohorts ensuring reproducibility across labs, scanners, and populations.
We have witnessed the weight of uncertainty, the anxiety of waiting, and the power of precise answers.
We couldn't accept the status quo when you know deep inside that we can change it!
That is why we built DiaDeep, not just another AI company, but a team of fighters who believe patients deserve better and we can make a difference both now and in the long run.
As our CEO, Sanae Salhi, says:
“It’s not a sprint, it’s a marathon” and every one of us is willing to run it. Not for ourselves, but for all those fighting for their lives every day.
We aim to bring clarity, trust and insights to cancer diagnosis
We start by listening to pathologists, oncologists and care teams, designing solutions that reflect the realities of clinical practice.
Our AI is rigorously tested with experts, ensuring every result is reliable and ready for real-world decisions.
Seamless integration means our tools support your team, no disruption, just enhanced expertise and efficiency.
We evolve with every case, learning and adapting to deliver better answers and outcomes for every patient.
We know trust is earned. Here are answers to the questions we hear most from pathologists, oncologists, and hospital leaders so you can feel confident, informed and supported at every step.
